IPP Bureau
Panacea Biotec posts Q1 FY24 consolidated PAT at Rs. 10.98 Cr
By IPP Bureau - August 13, 2023
Panacea Biotec has reported total income of Rs. 135.27 crores during the period ended June 30, 2023
LyondellBasell awarded the 2023 Global Medical Plastics Company of the year
By IPP Bureau - August 13, 2023
LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions
WuXi XDC and Boostimmune sign MoU for integrated services
By IPP Bureau - August 13, 2023
Boostimmune will have access to WuXi XDC's fully integrated one-stop bioconjugate platform
Gujarat Themis Biosyn posts Q1 FY24 PAT at Rs. 17.72 Cr
By IPP Bureau - August 12, 2023
Gujarat Themis Biosyn has reported total income of Rs. 50.66 crores during the period ended June 30, 2023
IPCA Laboratories posts Q1 FY24 consolidated PAT at Rs. 162.82 Cr
By IPP Bureau - August 12, 2023
IPCA Laboratories has reported total income of Rs. 1632.43 crores during the period ended June 30, 2023
Health Minister Mandaviya inaugurates the phase II of Mass Drug Administration initiative for Lymphatic Filariasis
By IPP Bureau - August 12, 2023
India is committed to eliminating Lymphatic Filariasis by 2027, three years ahead of the global target through mission mode, multi partner, multi sector targeted drive
Govt. of Arunachal, Sir Ganga Ram Hospital and Religare Enterprises sign an MoU to support the development of the state’s healthcare services
By IPP Bureau - August 12, 2023
The first such initiative under the MoU will involve establishing a Centre of Excellence for Renal Sciences at the Tomo Riba Institute of Health & Medical Sciences (TRIHMS)
DuPont to commercialize pharma silicone tubing ‘Liveo’ produced in China
By IPP Bureau - August 12, 2023
DuPont Liveo continued investments demonstrate our long-term commitment to the healthcare industry
Dimensionless Technologies launches AushadhAI to support pharma supply chain
By IPP Bureau - August 12, 2023
AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents
India is set to become the global hub of medical technology and devices: Dr Mandaviya
By IPP Bureau - August 11, 2023
The medical device sector is considered as one of the sunrise sectors in the country
SMS Lifesciences India posts Q1 FY24 consolidated loss at Rs. 1.79 Cr
By IPP Bureau - August 10, 2023
The company has reported total income of Rs. 75.26 crores during the period ended June 30, 2023
Granules India posts Q1 FY24 revenue from operations at Rs. 985.5 Cr
By IPP Bureau - August 10, 2023
API, PFI, and Finished dosages contribute 30%, 15%, and 55% of revenue from operations respectively for Q1FY24
Hester Biosciences posts Q1 FY24 consolidated PAT at Rs. 5.86 Cr
By IPP Bureau - August 10, 2023
Hester Biosciences has reported total income of Rs. 88.99 crores during the period ended June 30, 2023
Suven Life Sciences posts Q1 FY24 consolidated loss at Rs. 24.09 Cr
By IPP Bureau - August 10, 2023
Suven Life Sciences has reported total income of Rs. 9.43 crores during the period ended June 30, 2023
Natural Capsules Q1 FY24 consolidated PAT falls to Rs. 1.82 Cr
By IPP Bureau - August 10, 2023
Natural Capsules Ltd. has reported total income of Rs. 37.87 crores during the period ended June 30, 2023
